Arkema (OTCMKTS:ARKAY – Get Free Report) was downgraded by investment analysts at Kepler Capital Markets from a “strong-buy” rating to a “hold” rating in a research note issued to investors on Friday,Zacks.com reports.
Several other equities research analysts have also recently commented on the stock. Zacks Research cut shares of Arkema from a “hold” rating to a “strong sell” rating in a research report on Tuesday, January 6th. The Goldman Sachs Group upgraded shares of Arkema from a “hold” rating to a “buy” rating in a research report on Tuesday, February 10th. Barclays downgraded Arkema from a “hold” rating to a “strong sell” rating in a research note on Tuesday, November 11th. Finally, Deutsche Bank Aktiengesellschaft lowered Arkema from a “buy” rating to a “hold” rating in a research note on Monday, November 24th. Two analysts have rated the stock with a Buy rating, three have issued a Hold rating and three have assigned a Sell rating to the company’s stock. According to MarketBeat.com, Arkema presently has an average rating of “Reduce”.
Read Our Latest Stock Analysis on Arkema
Arkema Stock Up 0.4%
Arkema Company Profile
Arkema SA is a global specialty chemicals and advanced materials company headquartered in Colombes, France. Established in 2004 as a spin-off from Total’s chemicals division, the company offers a broad portfolio of high-performance materials designed to improve durability, thermal and chemical resistance, and environmental performance across diverse industries.
Arkema’s operations are organized into four core segments. Adhesive Solutions delivers bonding, sealing, and coating technologies for markets such as packaging, medical devices, and consumer goods.
Recommended Stories
- Five stocks we like better than Arkema
- The gold chart Wall Street is terrified of…
- This makes me furious
- America’s 1776 happening again
- Buy this Gold Stock Before May 2026
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
Receive News & Ratings for Arkema Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arkema and related companies with MarketBeat.com's FREE daily email newsletter.
